Summary This study examined the effect of transforming growth factor beta-I (TGF-PI) on c-myc, RBI, junB and p53 expression together with pRb phosphorylation, in carcinoma-derived and normal human oral keratinocytes with a range of inhibitory responses to this ligand. Amplification of c-myc was observed in eight of eight tumour-derived cell lines and resulted in corresponding mRNA expression. The down-regulation of c-myc expression by TGF-P1 predominantly reflected growth inhibition by but 
The human transforming growth factor beta family of growth factors P2, 133) are highly conserved, ubiquitous peptides that exhibit a remarkable diversity of biological action, notably the inhibition of epithelial cell growth. Many malignant human epithelial cell lines are either refractory or partially responsive to TGF-11, possibly owing to the accumulation of multiple genetic defects (Fynan and Reiss, 1993) . This has led to the concept that loss of TGF-P responsiveness is a critical step in epithelial tumour development and results in unrestrained tumour cell growth.
TGF-,B signal transduction is mediated through types I, II and III (P-glycan) TGF-P receptors (Massague, 1992) and, while defects in TGF-p-receptor profiles have been reported previously in malignant cell lines (Kimchi et al., 1988; Segarini et al., 1989) , the events distal to legend-receptor interaction are unclear and anomalies at any point on the signalling pathway(s) could contribute to loss of TGF-1 responsiveness. TGF-P1 inhibits c-myc gene transcription (Coffey et al., 1988; Pietenpol et al., 1990a) and leads to the arrest of epithelial cells in the late GI phase of the cell cycle (Munger et al., 1992) . The negative effects of TGF-1I on c-myc transcription have been linked to the phosphorylation of the RBI-suppressor gene product because viral oncoproteins that bind and inactivate pRb also abrogate the response of c-myc to TGF-P1 (Pietenpol et al., 1990b) . It has been demonstrated that hyperphosphorylation of pRB at the GI/S interphase is prevented by TGF-,11 and thus pRb remains in an inactive growth suppressive form (Laiho et al., 1990a) . Other TGF-P1 signal transduction pathways, however, are likely to exist because TGF-P1 can repress c-myc transcription independently of functional pRb (Zentella et al., 1991) and enhance junB transcription in cells independently of cell cycle control (Chen et al., 1993 (Laiho et al., 1990b (Laiho et al., , 1991 ; such data may be more relevant to understanding the role of TGF-1 in epithelial carcinogenesis.
It has been suggested that the p53 tumour-suppressor gene may also be involved in TGF-P1 signal transduction. It has been reported that the majority of malignant epithelial cell lines are not only resistant to TGF-P1 but also harbour p53
mutations (Fynan and Reiss, 1993) , that transfection of mutant p53 leads to a partial loss of response to TGF-P1 in human bronchial epithelial cells (Gerwin et al., 1992) and that TGF-P1 down-regulates p53 expression in the immortalised HaCaT keratinocyte cell line (Landesman et al., 1992) . By contrast, there is evidence to show that transfection of mutant p53 into human cell lines does not necessarily lead to tumour progression or loss of response to TGF-p1. The role of p53 in TGF-P signal transduction, therefore, requires clarification.
We have developed tumour-derived human oral keratinocyte cell lines with a range of biological responses to TGF-,13, from marked inhibition to complete loss of response (Prime et al., 1994) and with known ras and p53 gene profiles (Yeudall et al., , 1995 . All of these cell lines express types I and II TGF-P receptors in varying proportions (Prime et al., 1994) and, therefore, the possibility remains that changes in the response of the cell lines to exogenous TGF-P1 reflect alterations of growth-regulatory genes. The purpose of the present study was to determine the effects of TGF-1I on c-myc, RBI, junB and p53 expression, together with Rb phosphorylation, in normal and tumour-derived keratinocytes. This data was examined in the context of the inhibition of cell proliferation by TGF-P1 and what is previously known of the genetic abnormalities in these cell lines.
Materials and methods

Cell culture
The growth of keratinocyte cell lines from human oral squamous cell carcinomas has been described previously (Prime et al., 1990; Parkinson and Yeudall, 1991) (Figure 1 ).
In order to determine whether amplification of c-myc genomic sequences resulted in increased levels of c-myc mRNA, Northern blot analysis of total cellular RNA was carried out. As demonstrated in Figure 2 , c-myc mRNA expression was found to correspond to the level of c-myc gene amplification.
The effect of TGF-PI on c-myc transcription in the growth inhibited cell lines H376 and H400 is shown in Figure 3a . Exposure of all responsive cell lines (including normal keratinocytes and H357; data not shown) and two of four partially responsive cell lines (HI57, H413) resulted in a rapid (1-5 h) down-regulation of c-myc transcription. By contrast, c-myc transcription was unaltered in H103 and T-45 (partially responsive to TGF-P1) and H314 (refractory to TGF-P1) cell lines following treatment with exogenous TGF-P1 (2ngml-') for up to 24h (Figure 3b ). Examining the effect of TGF-P11 (2 ng ml-') for 24 h on c-myc protein exp- ression, using Western blot analysis, confirmed the results obtained by Northern blotting. This is shown in Figure 3c for H357, H376 (responsive), H103 (partially inhibited) and H314 (refractory). Figure 4 for the markedly growth-inhibited cell line H400, the partially inhibited cell lines H103, H157 and H413 and the refractory cell line H314. levels of p53 (Yeudall et al., 1995) and, therefore, TGF-p1-mediated effects could not be detected. In addition, the HaCaT keratinocyte cell line (in which down-regulation of p53 protein expression has been demonstrated previously following treatment with TGF-p1; Landesman et al., 1992) was used as a control in these experiments. In the present study, no effect on p53 expression was observed in HaCaT cells in response to TGF-11 exposure.
Discussion
The mechanisms by which TGF-P1 mediate growth inhibition after binding to specific cell surface receptors remain unknown. In the present study, we have examined the effect of TGF-P1I on c-myc, RBI, jun B and p53 expression in normal human oral keratinocytes and tumour-derived cell lines which exhibit a range of inhibitory responses to TGF-P1 (Prime et al., 1994) . The data are summarised in Table I, together with previously published findings concerning these cell lines.
In normal human keratinocytes, TGF-P1 reversibly inhibits cell growth in the late GI phase of the cell cycle (Munger et al., 1992) and this is thought to be associated with a marked reduction of c-myc expression (Pietenpol et al., 1990a) . In the present study, all eight tumour-derived cell lines exhibited c-myc gene amplification and a corresponding increase in mRNA expression. We have shown previously that six of the eight cell lines in this study contained isochromosome 8q and the others harboured increased copies of chromosome 8, implying an increase in copy number of the c-myc gene (8q24). The results of the present study are consistent with previous observations relating c-myc gene amplification to overexpression (Alitalo et al., 1987) . If c-myc levels mediate the growth inhibitory function of TGF-,1, it might be expected that overexpression of c-myc protein would enable tumour cells to overcome TGF-PI-induced growth arrest.
The present study demonstrates that c-myc mRNA overexpression does not abrogate TGF-P1 growth inhibition. Further, we demonstrate that c-myc down-regulation by TGF-1I corresponds to growth inhibition by this ligand in six of eight tumour-derived cell lines. In two cell lines which were partially responsive to TGF-01 (H103, T-45), however, c-myc expression was not down-regulated. These data can be interpreted by suggesting that TGF-P1 can inhibit cell cycle progression outwith c-myc regulation.
The fact that HPV 16 E7, the SV40 T antigen and the adenovirus Ela protein not only bind and inactivate the underphosphorylated Rb protein (pRb'05) but also prevent the down-regulation of c-myc expression by TGF-p1, has led to the concept that the Rb protein is involved in the transcriptional regulation of c-myc by TGF-P1 (Pietenpol et al., 1990b (Yeudall et al., 1995) indicating that the cyclin D-cdk4 and cyclin E-cdk2 pathways, which are p53 dependent (Hunter and Pines, 1994; Ewen et al., 1995) , are likely to be non-functional. TGF-B13, therefore, is likely to regulate Rb phosphorylation independently of these pathways. The question of how TGF-3 regulates c-myc down-regulation independently of Rb phosphorylation and how TGF-pinduced growth control can occur independently of c-myc regulation remains an enigma. One possible mechanism is the regulation of the cell cycle via the cyclin-inhibitory protein p21, which binds and inactivates components of the DNA replicatory machinery (Waga et al., 1994) ; interestingly, recent data indicate that p21 acts independently of p53 (Parker et al., 1995) .
The results of the present study indicate that control of junB expression is also independent of cellular proliferation, confirming previous observations in mink lung epithelial cells (Chen et al., 1993) . TGF-P is known to bind to three highaffinity cell surface receptors termed types I, II and III (Massague, 1992) . It has previously been demonstrated that both type I and II receptors are required for TGF-P signalling (Laiho et al., 1990b; Wrana et al., 1992) . Extending these findings, Chen et al. (1993) have proposed that there are different TGF-P1 signalling pathways mediated by type I and II receptors, the former involving the induction of junB expression and the elaboration of extracellular matrices and the latter including c-myc down-regulation and inhibition of cell growth. It is tempting to speculate that both junB and Rb are involved in signalling pathways leading to extracellular matrix (ECM) elaboration, but this obviously requires experimental confirmation. All the cell lines in the present study express both type I and II receptors in variable proportions (Prime et al., 1994) . Our results indicate that the expression of one specific TGF-, receptor does not correlate with the control of c-myc, Rb or junB but do not exclude the possibility of interdependent receptors with separate signalling pathways. The possibility of divergent receptor-mediated TGF-, signal transduction mechanisms, however, is currently being questioned (Weiser et al., 1994; Wrana et al., 1994) and is likely to be an area of intense study in the future.
We have demonstrated previously that all of the cell lines in the present study contain mutant p53 in either a missense (H103, H314, H357, H400, H413, T-45) or nonsense (H157, H376) form. The fact that the nonsense mutations in H157 and H376 resulted in a truncated protein (Yeudall et al., 1995) eand the cells are markedly inhibited by TGF-P1 (Prime et al., 1994) indicates that p53-independent pathways are likely to be involved in TGF-P signal transduction. This conclusion differs from previous observations (Gerwin et al., 1992; Landesman et al., 1992) The relationship between activation of ras genes and the cellular responsiveness to TGF-,B is unclear. We have shown previously that transfection of the mutant cellular Ha-ras gene into the human immortalised HaCaT keratinocyte line resulted in a progressive loss of response to TGF-P1 (Game et al., 1992) , findings that are entirely consistent with p21-ras being involved in TGF-,11 signal transduction (Howe et al., 1993) . The results of the present study indicate that TGF-P1 can inhibit epithelial cell growth despite the presence of Ha-ras mutations (H357); previous studies have shown the presence of viral and cellular mutant ras gene in TGF-,Bsensitive cell lines (Manning et al., 1991; Missero et al., 1991) . The data of the present study indicate that TGF-P1 signal transduction can occur independently of ras mutation and support the findings of Yan et al. (1994) showing that TGF-P1 can activate two different signal transduction pathways, one ras dependent and another ras independent.
Elucidating the mechansims that control the cell cycle is fundamental to an understanding of cell behaviour and malignancy. The results of the present study indicate that TGF-p-induced growth control can exist independently of the presence of mutant p53 and the control of Rb phosphorylation and c-myc down-regulation in tumour-derived human oral keratinocytes. Taken together, the results suggest that multiple mechanisms control TGF-,B growth inhibition and that the abrogation of one pathway does not necessarily lead to loss of TGF-B-induced growth control.
